AU5107496A - Medicament preparation for angiotensin converting enzyme (ace)-inhibitors - Google Patents

Medicament preparation for angiotensin converting enzyme (ace)-inhibitors

Info

Publication number
AU5107496A
AU5107496A AU51074/96A AU5107496A AU5107496A AU 5107496 A AU5107496 A AU 5107496A AU 51074/96 A AU51074/96 A AU 51074/96A AU 5107496 A AU5107496 A AU 5107496A AU 5107496 A AU5107496 A AU 5107496A
Authority
AU
Australia
Prior art keywords
ace
inhibitors
converting enzyme
angiotensin converting
medicament preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51074/96A
Inventor
Gunter Cordes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labtec Gesellschaft fuer Technologische Forschung und Entwicklung mbH
Original Assignee
Labtec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labtec GmbH filed Critical Labtec GmbH
Publication of AU5107496A publication Critical patent/AU5107496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51074/96A 1996-03-13 1996-03-13 Medicament preparation for angiotensin converting enzyme (ace)-inhibitors Abandoned AU5107496A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/001062 WO1997033569A1 (en) 1996-03-13 1996-03-13 Medicament preparation for angiotensin converting enzyme (ace)-inhibitors

Publications (1)

Publication Number Publication Date
AU5107496A true AU5107496A (en) 1997-10-01

Family

ID=8166177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51074/96A Abandoned AU5107496A (en) 1996-03-13 1996-03-13 Medicament preparation for angiotensin converting enzyme (ace)-inhibitors

Country Status (2)

Country Link
AU (1) AU5107496A (en)
WO (1) WO1997033569A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625201A1 (en) * 1996-06-24 1998-01-08 Hans Peter Buerkle Dosage formulation for drugs with acid stable groups
JP2011503048A (en) * 2007-11-08 2011-01-27 グラクソ グループ リミテッド Pharmaceutical formulation
CN107213138B (en) * 2017-08-07 2020-12-18 北京罗诺强施医药技术研发中心有限公司 Method and pharmaceutical composition for treating hypertension by timed release of drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601128A (en) * 1983-06-15 1985-01-07 Shionogi & Co Ltd Long-acting cefaclor preparation
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
FR2715067B1 (en) * 1994-01-14 1996-04-05 Ethypharm Lab Prod Ethiques New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.
DE4431832A1 (en) * 1994-09-07 1996-03-14 Cordes Guenter Dr Delayed release form of captopril in pellets in capsules

Also Published As

Publication number Publication date
WO1997033569A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
AU9187598A (en) Oral preparation
AU3214797A (en) Engineering oral tissues
AU4322797A (en) Protruding case for mail
AU8497898A (en) Order pick system
AU3803097A (en) Battery operating system
AU1628499A (en) Well isolation system
AU3102797A (en) Cell adhesion inhibiting compounds
AU2654299A (en) Wheelchair
AU2186797A (en) Pharmaceutically useful compounds
AU6417998A (en) Automatic conversion system
AU7045796A (en) One-trip window-milling system
AU3493299A (en) Improved centrifuge system
AU6811098A (en) Evacuation system
AU2300697A (en) Improved membrane
AU6308699A (en) Cell-cap connection system
AU4646097A (en) Improved multiple-burst-correction system
AU7830498A (en) Instant yogurt preparation
AU2688399A (en) Vessel securing system
AU5107496A (en) Medicament preparation for angiotensin converting enzyme (ace)-inhibitors
AU3225097A (en) Immunotherapy for autoimmune disease
AU7236496A (en) Biocompatibility for solid surfaces
AU4707599A (en) Denture system
AU7353598A (en) Implant system
AU9287998A (en) System for dental components
AU1041597A (en) Remedy for tragomaschalia containing adrenocorticosteriodal preparation